Hanmi Pharm Soars 30% on $2.3 Billion Genentech Obesity Drug Deal 
SK Hynix Shares Fall as Workers Reject Wage Deal 
Samsung Shares Tumble 8% as $79 Billion Return Plan Disappoints 
China EV Stocks Slide as Door Handle Recall Hits 4.3 Million Vehicles 
Google Expands Gemini Enterprise With AI Tools for Legal Sector 
Adidas, Puma Shares Fall as Dick’s Sporting Goods Cuts Outlook 
Luxshare Shares Rise as First-Half Profit Jumps 18% 
Ampol Profit Surges as Refining Margins Hit Record Highs 
Nvidia Options Price in $280 Billion Earnings Swing 
Tokio Marine Eyes Multibillion-Dollar Suncorp Takeover 
Apple Cuts Over 200 Siri, Vision Pro Jobs in AI Shift 
Nvidia Eyes Perplexity Investment at $30 Billion Valuation 
Australia’s Big Four Banks Face Mortgage Slowdown as Valuations Draw Scrutiny 
SoftBank Plans Record $6.3 Billion Bond Sale to Fund OpenAI Investments 
Trump Buys SpaceX Shares After Record IPO 
Alibaba Raises $10.2 Billion to Expand AI Infrastructure 
Woodside Drops $5 Billion Clean Energy Plan as Profit Rises 7% 
Add as a preferred source on Google
DELRAY BEACH, Fla., April 30, 2018 -- PetMed Express, Inc. (NASDAQ:PETS) will announce its financial results for the fiscal year ended March 31, 2018 on Monday, May 7, 2018 at 8:00 A.M. Eastern Time, then at 8:30 A.M. Eastern Time, Menderes Akdag, the Company’s Chief Executive Officer and President, will host a conference call to review the financial results.
To access the call, which is open to the public, please dial (888) 455-1758 (toll free) or (203) 827-7025, ten minutes prior to the scheduled start time. Callers will be required to supply PETMEDS as the passcode, and will be placed on hold with music until the call begins.
For those unable to participate in the live event, the call will be available for replay from 10:00 A.M. Eastern Time on May 7, 2018 until May 21, 2018 at 11:59 P.M. Eastern Time. To access the replay, call (866) 423-4837 (toll free) or (203) 369-0849, and enter passcode 5500.
Founded in 1996, PetMed Express is America’s Largest Pet Pharmacy, delivering prescription and non-prescription pet medications and other health products for dogs and cats at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and on the Internet through its website at www.1800petmeds.com.
This press release may contain “forward-looking” statements, as defined in the Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission, that involve a number of risks and uncertainties, including the Company’s ability to meet the objectives included in its business plan. Important factors that could cause results to differ materially from those indicated by such “forward-looking” statements are set forth in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the PetMed Express Annual Report on Form 10-K for the year ended March 31, 2017. The Company’s future results may also be impacted by other risk factors listed from time to time in its SEC filings, including, but not limited to, the Company's Form 10-Q and its Annual Report on Form 10-K.
For investment relations contact PetMed Express, Inc., Bruce S. Rosenbloom, CFO, 561-526-4444.
| Contact: | Bruce S. Rosenbloom, CFO | |
| Phone: | (561) 526-4444 | |
| Fax: | (561) 526-4434 |
